BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1733796)

  • 1. Inhibition of aspartic proteinases by synthetic peptides derived from the propart region of human prorenin.
    Richards AD; Kay J; Dunn BM; Bessant CM; Charlton PA
    Int J Biochem; 1992 Feb; 24(2):297-301. PubMed ID: 1733796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of aspartic proteinases by propart peptides of human procathepsin D and chicken pepsinogen.
    Fusek M; Mares M; Vágner J; Voburka Z; Baudys M
    FEBS Lett; 1991 Aug; 287(1-2):160-2. PubMed ID: 1879525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The selectivity of statine-based inhibitors against various human aspartic proteinases.
    Jupp RA; Dunn BM; Jacobs JW; Vlasuk G; Arcuri KE; Veber DF; Perlow DS; Payne LS; Boger J; de Laszlo S
    Biochem J; 1990 Feb; 265(3):871-8. PubMed ID: 2407237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid sequence of endothiapepsin. Complete primary structure of the aspartic protease from Endothia parasitica.
    Barkholt V
    Eur J Biochem; 1987 Sep; 167(2):327-38. PubMed ID: 3305016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New monoclonal antibodies directed against the propart segment of human prorenin as a tool for the exploration of prorenin conformation.
    Cohen P; Simon D; Badouaille G; Mani JC; Portefaix JM; Pau B
    J Immunol Methods; 1995 Jul; 184(1):91-100. PubMed ID: 7622873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Renin-angiotensin system].
    Suzuki F
    Nihon Rinsho; 1992 Dec; 50(12):2879-84. PubMed ID: 1491444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrolysis by plasma kallikrein of fluorogenic peptides derived from prorenin processing site.
    Almeida PC; Chagas JR; Cezari MH; Juliano MA; Juliano L
    Biochim Biophys Acta; 2000 Jun; 1479(1-2):83-90. PubMed ID: 11004531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pH dependence of the hydrolysis of chromogenic substrates of the type, Lys-Pro-Xaa-Yaa-Phe-(NO2)Phe-Arg-Leu, by selected aspartic proteinases: evidence for specific interactions in subsites S3 and S2.
    Dunn BM; Valler MJ; Rolph CE; Foundling SI; Jimenez M; Kay J
    Biochim Biophys Acta; 1987 Jun; 913(2):122-30. PubMed ID: 3109484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspartic proteinases: their activation and structural studies.
    Turk V; Puizdar V; Lah T; Kregar I
    Prog Clin Biol Res; 1982; 102 Pt C():75-86. PubMed ID: 6762543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-step purification of cathepsin D by affinity chromatography using immobilized propeptide sequences.
    Wittlin S; Rösel J; Stover DR
    Eur J Biochem; 1998 Mar; 252(3):530-6. PubMed ID: 9546670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-ray structural studies of mammalian aspartic proteinases.
    Cooper JB; Newman MP
    Adv Exp Med Biol; 1991; 306():47-61. PubMed ID: 1812745
    [No Abstract]   [Full Text] [Related]  

  • 12. Exploring the binding preferences/specificity in the active site of human cathepsin E.
    Rao-Naik C; Guruprasad K; Batley B; Rapundalo S; Hill J; Blundell T; Kay J; Dunn BM
    Proteins; 1995 Jun; 22(2):168-81. PubMed ID: 7567964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparisons of the three-dimensional structures, specificities and glycosylation of renins, yeast proteinase A and cathepsin D.
    Aguilar CF; Dhanaraj V; Guruprasad K; Dealwis C; Badasso M; Cooper JB; Wood SP; Blundell TL
    Adv Exp Med Biol; 1995; 362():155-66. PubMed ID: 8540315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-directed mutagenesis of human prorenin. Substitution of three arginine residues in the propeptide with glutamine residues yields active prorenin.
    Yamauchi T; Nagahama M; Watanabe T; Ishizuka Y; Hori H; Murakami K
    J Biochem; 1990 Jan; 107(1):27-31. PubMed ID: 2185237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of latent forms of renin using antibodies raised against the propart segment of human prorenin: validation with representative samples of ovarian cyst and follicular fluids.
    Price-Jones MJ; Charlton PA; Bessant CM; Harrison TM; Darke BM; Lees WE; Kay J
    Clin Exp Hypertens; 1993 Jul; 15(4):619-40. PubMed ID: 8374607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrolysis by cathepsin B of fluorescent peptides derived from human prorenin.
    Almeida PC; Oliveira V; Chagas JR; Meldal M; Juliano MA; Juliano L
    Hypertension; 2000 Jun; 35(6):1278-83. PubMed ID: 10856277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of milk-clotting enzymes towards bovine kappa-casein.
    Drøhse HB; Foltmann B
    Biochim Biophys Acta; 1989 May; 995(3):221-4. PubMed ID: 2495817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of porcine pepsin by two substrate analogues containing statine. The effect of histidine at the P2 subsite on the inhibition of aspartic proteinases.
    Maibaum J; Rich DH
    J Med Chem; 1988 Mar; 31(3):625-9. PubMed ID: 3126296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural characterization of activation 'intermediate 2' on the pathway to human gastricsin.
    Khan AR; Cherney MM; Tarasova NI; James MN
    Nat Struct Biol; 1997 Dec; 4(12):1010-5. PubMed ID: 9406551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of human prorenin by neutrophil elastase.
    Takada Y; Maruta H; Wagner B; FA XG; James HL; Erdös EG
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1225-30. PubMed ID: 3316266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.